DAVID'S, Bermuda, Dec. 15, 2008 (GLOBE NEWSWIRE) -- Warner Chilcott Limited (Nasdaq:WCRX) today announced that the Company ... domestic and international non-financial stocks on The NASDAQ Stock Market(r) based on …
Each of these rates a “D” (“sell”) or “F” overall (“strong sell”). Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures.
(Reuters) - Generic drugmaker Actavis Inc ACT.N, which has been the subject of takeover speculation, plans to buy specialty pharmaceutical company Warner Chilcott Plc WCRX.O for $5 billion (3.2 billion pounds) in stock. The …
Men’s Wearhouse Inc. (NYSE: MW) named value stock of the day at Zacks ... Warner Chilcott plc (NASDAQ: WCRX) …
On Monday, generic drug maker Actavis Inc. (NYSE: ACT) announced plans to purchase specialty pharmaceutical company Warner Chilcott (NASDAQ: WCRX) in an all-stock deal valued around $8.5 billion. Actavis management will …
WCRX closed Friday's regular trading session at $16.06, up $0.49 or 3.15% on a volume of 2.53 million shares, higher …
At $4, Jim Cramer would buy Huntington Bancshares Incorporated (HBAN). This stock closed today at $5.37. Cramer likes Warner Chilcott Plc (NASDAQ: WCRX) and its huge dividend yield. Warner Chilcott Plc (WCRX) gained 4.66% today.
This week I’ve got seven pharma stocks to sell. Here they are, in alphabetical order ... Hospira Inc. (NYSE:HSP) is a specialty big pharma stock that offers a portfolio of products including oncology injectables. Since the start of 2011, …
against Warner Chilcott Limited ("Warner Chilcott" or the "Company") (Nasdaq:WCRX) and certain officers, on behalf of purchasers of the common stock of the Company during the period from September 20, 2006 through September 26, …
NEW YORK (Reuters) - Generic drugmaker Actavis ACT.N, the subject of intense takeover speculation, may have found its best defense: a potential purchase of Warner Chilcott Plc WCRX.O ... Actavis were discussing an all-stock merger …